Clinical Trials Logo

Clinical Trial Summary

Purpose of this study is to investigate 1. The effect of Dry cupping therapy on T-Lymphocyte in post covid-19 patients. 2. The effect of Dry cupping therapy on serum Cytokine in post covid-19 patients. 3. The effect of Dry cupping therapy on Immunoglobulin IgA. 4. The effect of Dry cupping therapy on Immunoglobulin IgM. 5. The effect of Dry cupping therapy on Immunoglobulin IgG. seventy six patients of both genders with deficiency in T-Lymphocyte number,,higher level of serum cytokine and lower immunoglobulin IgA,IgM,IgG after two weeks of recovery from covid-19 . Age range from Twenty one to Sixty six years old .They participated in the study and recruited from surveillance unit of Shobra general hospital .These patients recruited by phone and have been offered to participate in the programme.The patients were divided equally into two groups (A and B). Assessment was done before and after treatment. T-Lymphocyte, serum cytokine and immunoglobulin IgA, IgM and IgG were analyzed by kenza 240 TX from fluorescence-labeled flow cytometry. Disposable cupping therapy instrument was used in treatment of group (A) in addition to traditional medical treatment in the form of vitamin C, D and anticoagulant drugs. Traditional medical treatment only was used in treatment of group (B).The obtained results of this study will determine the significant improvement of participated two groups. .


Clinical Trial Description

Patient were selected randomly and distributed in two groups by computer generation. The sample size was calculated using the G*Power software (version 3.0.10). F-test MANOVA within and between interaction effects was selected. Considering a power of 0.80, an α level of 0.05 (2 tailed) and effect size of 0.39; two groups and response variables of five, a generated sample size of at least 38 participants per group was required and total sample size of 76 subjects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05901337
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase N/A
Start date March 7, 2022
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04592835 - To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 Phase 1
Not yet recruiting NCT05083104 - Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
Completed NCT05162534 - Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
Completed NCT04853979 - Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure N/A
Completed NCT05369676 - To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 Phase 1/Phase 2
Recruiting NCT06349720 - Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
Completed NCT04407130 - Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. Phase 2
Not yet recruiting NCT04427878 - Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients? N/A
Terminated NCT04541485 - To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) Phase 1
Withdrawn NCT04374903 - Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients N/A